Articles

Gov. Brian Kemp made a stop in Southwest Georgia for Danimer Scientific’s groundbreaking ceremony in Bainbridge. It’s a $700 million dollar expansion. The company is a leading developer and manufacturer of biodegradable materials. The new plant will be a 2,000,000-square-foot facility. Officials say it’s the largest plant that will make polyhydroxyalkanoate, a biodegradable plastic that…

Drug companies are preparing for Omicron to be the next major challenge of the pandemic. The newest variant’s mutations could weaken vaccine protection, though that remains unknown. While much is still uncertain, the pharmaceutical industry is already planning its counterattack. Vaccine and drug developers are preparing for the Omicron variant to turn into the next…

GeoVax Intellectual Property Portfolio Includes More than 70 Granted/Pending Patent Applications GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent Application No. 16/068,527 entitled “Compositions and Methods for Generating an Immune…

Expands Alcon’s leading surgical portfolio and leverages the company’s commercial execution expertise Strong safety and efficacy profile evidenced by five-year study on Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device Indicated to lower intraocular pressure for open-angle glaucoma patients in connection with cataract surgery*, Hydrus Microstent is part of a large surgical glaucoma market…

Expanded authorization allows more Americans to receive a booster dose to help preserve a high-level of protection against COVID-19 Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to…

Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmaceutical company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV), and IRBM, a drug discovery and early development research institute and global contract research organization, announced today they entered into an agreement for Antios to purchase the IP rights to a novel series of fourth-generation…

InVIEW℠ provides real-time data analytics and reports to improve patient care  Vizzia Technologies, a leading software and managed service provider of real-time location systems (RTLS) for healthcare organizations, has commercially released a significant upgrade to its InVIEW℠ software platform. Vizzia InVIEW℠ offers a faster, more secure, cloud-based experience, with industry-requested features, powerful analytics, and new maps. The…

Today, the Advanced Medical Technology Association (AdvaMed) released the following statement from President and CEO Scott Whitaker regarding the Centers for Medicare and Medicaid Services (CMS) recission of the Medicare Coverage for Innovative Technologies (MCIT) final rule: “The MCIT rule was truly transformational for Medicare patients and doctors looking for life-saving and life-enhancing breakthrough medical…

Robert Califf, President Biden’s new pick to lead the Food and Drug Administration, doesn’t have much to show for his first tenure at the agency. His grand plans for modernizing the way drug makers and the FDA collect patient data were shelved in 2017 after he left the agency’s top spot. His efforts to ban…

Phase 2 Vaccine Designed to Enhance Response for Immunocompromised Patients Complements GeoVax’s Pan-Coronavirus Vaccine Program GeoVax Labs Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that it has entered into an exclusive license agreement with City of Hope, a world-renowned cancer research and treatment organization. The agreement grants…